Use of pharmacogenetics to optimize immunosuppressant therapy in kidney-transplanted patients
V Urzì Brancati, C Scarpignato, L Minutoli, G Pallio - Biomedicines, 2022 - mdpi.com
… In particular, genetic factors have been estimated to play a role in this variability because of
… on the tacrolimus dose required to reach the target exposure in kidney transplant recipients […
… on the tacrolimus dose required to reach the target exposure in kidney transplant recipients […
Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives
… factors potentially impacting tacrolimus metabolism, and represents a simple and inexpensive
tool that could be … , and assist in individualizing and optimizing tacrolimus therapy [7]. …
tool that could be … , and assist in individualizing and optimizing tacrolimus therapy [7]. …
Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation
M Yu, M Liu, W Zhang, Y Ming - Current drug metabolism, 2018 - ingentaconnect.com
… , including ethnicity, age, gender, concomitant medication, hepatic and renal dysfunction,
and genetic factors such as CYP3A5, CYP3A4 and ABCB1 SNPs [12, 16, 124]. Among them, …
and genetic factors such as CYP3A5, CYP3A4 and ABCB1 SNPs [12, 16, 124]. Among them, …
Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and …
X Chen, DD Wang, H Xu, ZP Li - Expert Review of Clinical …, 2020 - Taylor & Francis
… along with pharmacogenetics of tacrolimus in pediatric patients undergoing kidney
transplantation to identify factors that explain variability and determine dosage regimens. These …
transplantation to identify factors that explain variability and determine dosage regimens. These …
Pharmacogenetics based dose prediction model for initial tacrolimus dosing in renal transplant recipients
… 6th-day tacrolimus C 0 /D ratio with multiple factors, including … A dosing equation to calculate
the required tacrolimus dose/… have been made to optimize tacrolimus dosing based on the …
the required tacrolimus dose/… have been made to optimize tacrolimus dosing based on the …
Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations
JT Tang, LM Andrews, T van Gelder… - Expert opinion on …, 2016 - Taylor & Francis
… The authors concluded that optimization of initial Tac dosing using CYP3A5 … the first
dosing algorithm using a combination of genetic information and clinical factors in adult kidney …
dosing algorithm using a combination of genetic information and clinical factors in adult kidney …
Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives
AL Degraeve, S Moudio, V Haufroid… - Expert opinion on …, 2020 - Taylor & Francis
… In kidney transplantation, tacrolimus (TAC) is at the cornerstone … , physiologic but also genetic
factors. It was suggested that … fuel the state-of-the-art in regard to TAC therapy optimization …
factors. It was suggested that … fuel the state-of-the-art in regard to TAC therapy optimization …
Dosage optimization based on population pharmacokinetic analysis of tacrolimus in Chinese patients with nephrotic syndrome
T Lu, X Zhu, S Xu, M Zhao, X Huang, Z Wang… - Pharmaceutical …, 2019 - Springer
… was to merge genetic and non-genetic factors of tacrolimus … dosage regimen in Chinese
nephrotic syndrome patients. … with higher tacrolimus concentrations in liver or kidney transplant …
nephrotic syndrome patients. … with higher tacrolimus concentrations in liver or kidney transplant …
Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity
Y Bentata - Artificial organs, 2020 - Wiley Online Library
… AMT but without genetic factors having been clearly identified. Symptoms of acute … genetic
polymorphism as a biomarker in the use of tacrolimus might prevent drug toxicity and optimize …
polymorphism as a biomarker in the use of tacrolimus might prevent drug toxicity and optimize …
Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients
LM Andrews, YI Li, BCM De Winter, YY Shi… - Expert opinion on …, 2017 - Taylor & Francis
… disturbances, drug–drug interactions, genetic factors and importantly, non-adherence […
clinical benefit, concluding that optimizing the initial Tac dose based on CYP3A5 genotype …
clinical benefit, concluding that optimizing the initial Tac dose based on CYP3A5 genotype …